Abstract:Objective To compare the efficacy and safety between intranasal dexmedetomidine and traditional sedative drugs for rescue sedation during radiological scans in infants less than 12 months.Methods Based on an intention to treat protocol,300 infants who underwent radiological scans but were not adequately sedated after initial oral dose of 50 mg/kg chloral hydrate between January 1at,2016 and March 28th,2016 were enrolled in this prospective single-blinded randomized clinical trial.They were randomly divided into three groups.Intramuscular phenobarbital 5 mg/kg,second oral chloral hydrate 25 mg/kg and intranasal dexmedetomidine1 μg/kg were given in the three groups,respectively.The efficacy and safety of sedation were evaluated based onthe onset time,wake-up time,total sedation time,scanning time,success rate of sedation,hemodynamic changes of oxygen saturation and clinical side-effects.Binary logistic regression analysis was used to evaluate influencing factors related to success rate of sedation.Results The sedation onset time in dexmedetomidine group was significantly shorter than that in chloral hydrate group (P＜0.01).The wake-up time and the total sedation time in dexmedetomidine group were significantly longer than those in phenobarbital group and chloral hydrate group (both P＜0.01).There were no significant differences in the scanning time between the groups (both P＞0.05).The success rates of rescue sedation were 83％,79％ and 90％ in phenobarbital group,chloral hydrate group and dexmedetomidine group,respectively (both P＞0.05).Heart rate (HR) from 5 min after administration to sedative recovery was significantly lower than those at baseline in the three groups (all P＜0.01),and HR from 10 min after administration to the end of the scanning was also significantly lower than those at 5 min after administration in the three groups (all P＜0.01).However,no significant differences were found in HR between groups or intra-group at each time point (all P ＞ 0.05).Saturation pulse oxygen (SpO2) from 5 min after administration to sedative recovery were significantly higher than those at baseline in the three groups (all P＜ 0.01).However,no significant differences were found in SpO2 between groups or intra-group at each time point (all P＞0.05).Also,no significant differences were found in the incidence of adverse reactions among three groups (both P＞0.05).No influencing factors were identified in the binary logistic regression models (all P＞0.05).Conclusion Intranasal dexmedetomidine can be used effectively and safely in infants less than 12 months during radiological scans as a rescue sedative.A dosage of dexmedetomidine 1 μg/kg will not increase the incidence of side effects and hemodynamic changes.

Bioavailability of dexmedetomidine after intranasal administration

Absorption pharmacokinetics and feasibility of intranasal dexmedetomidine in patients under general anaesthesia

Pharmacokinetic and pharmacodynamic study of intranasal and intravenous dexmedetomidine

Mechanism-based population pharmacokinetic and pharmacodynamic modeling of intravenous and intranasal dexmedetomidine in healthy subjects

Safety, Pharmacokinetics/Pharmacodynamics, and Absolute Bioavailability of Dexmedetomidine Hydrochloride Nasal Spray in Healthy Subjects: A Randomized, Parallel, Escalating Dose Study

Efficacy and safety of intranasal dexmedetomidine versus oral chloral hydrate as sedatives for pediatric patients: a systematic review and meta-analysis

Pharmacokinetics of Intranasally Administered Dexmedetomidine in Chinese Children

Efficacy and safety of rescue sedation of intranasal dexmedetomidine versus traditional rescue techniques for radiological scans in infants less than 12 months

The Sedative Effects And The Attenuation Of Cardiovascular And Arousal Responses During Anesthesia Induction And Intubation In Pediatric Patients: A Randomized Comparison Between Two Different Doses Of Preoperative Intranasal Dexmedetomidine

Intranasal Dexmedetomidine for the Treatment of Pre-operative Anxiety and Insomnia: A Prospective, Randomized, Controlled, and Clinical Trial

Clinical Pharmacokinetics and Pharmacodynamics of Dexmedetomidine

Pharmacokinetic Study of Intranasal Dexamethasone and Methylprednisolone Compared with Intravenous Administration: Two Open-Label, Single-Dose, Two-Period, Two-Sequence, Cross-Over Study in Healthy Volunteers

Dexmedetomidine Versus Midazolam As Intranasal Premedication for Intravenous Deep Sedation in Pediatric Dental Treatment

Safety and efficacy of a novel dexmedetomidine nasal spray for pre-anesthetic sedation in children: a randomized, double-blind, placebo-controlled trial

Efficacy and Safety of Intranasal Dexmedetomidine vs. Oral Chloral Hydrate for Sedation in Children Undergoing Computed Tomography/Magnetic Resonance Imaging: A Meta-Analysis

Pharmacokinetics, absolute bioavailability and tolerability of ketamine after intranasal administration to dexmedetomidine sedated dogs

Intranasal atomized dexmedetomidine alone or in combination with ketamine or midazolam to sedate healthy dogs

Feasibility of Intranasal Dexmedetomidine in Treatment of Postoperative Restlessness, Agitation, and Pain in Geriatric Orthopedic Patients

A randomized double-blind trial of intranasal dexmedetomidine versus intranasal esketamine for procedural sedation and analgesia in young children

Application of dexmedetomidine in difficult airway patients with blind tracheal intubation

Prospective, randomized, double-blind, double-dummy, active-controlled, phase 3 clinical trial comparing the safety and efficacy of intranasal dexmedetomidine to oral midazolam as premedication for propofol sedation in pediatric patients undergoing magnetic resonance imaging: the MIDEX MRI trial